Editas Medicine, Inc.EDITNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank92
3Y CAGR+58.1%
5Y CAGR-8.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+58.1%/yr
vs -21.9%/yr prior
5Y CAGR
-8.6%/yr
Recent acceleration
Acceleration
+79.9pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 6.67 | +756.1% |
| 2024 | 0.78 | -64.7% |
| 2023 | 2.20 | +30.5% |
| 2022 | 1.69 | -47.9% |
| 2021 | 3.24 | -68.9% |
| 2020 | 10.44 | +85.1% |
| 2019 | 5.64 | +24.3% |
| 2018 | 4.54 | -23.8% |
| 2017 | 5.96 | +53.3% |
| 2016 | 3.88 | - |